CHIRON CAPITAL MANAGEMENT, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHIRON CAPITAL MANAGEMENT, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$233,000
-22.1%
10,200
-24.4%
0.17%
-22.9%
Q3 2021$299,000
+95.4%
13,500
+14.4%
0.22%
+71.7%
Q2 2021$153,000
+6.2%
11,800
+6.2%
0.13%
+4.1%
Q1 2021$144,000
+0.7%
11,108
+14.5%
0.12%
+6.1%
Q3 2020$143,0009,7000.12%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders